A detailed history of Avoro Capital Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 8,888,888 shares of ARWR stock, worth $174 Million. This represents 2.59% of its overall portfolio holdings.

Number of Shares
8,888,888
Previous 8,888,888 -0.0%
Holding current value
$174 Million
Previous $231 Million 25.51%
% of portfolio
2.59%
Previous 3.15%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$21.87 - $28.24 $7.29 Million - $9.41 Million
333,333 Added 3.9%
8,888,888 $231 Million
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $202 Million - $293 Million
7,425,555 Added 657.13%
8,555,555 $245 Million
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $12 Million - $17.5 Million
565,000 Added 100.0%
1,130,000 $34.6 Million
Q3 2023

Nov 14, 2023

BUY
$26.2 - $36.08 $5.44 Million - $7.49 Million
207,597 Added 58.08%
565,000 $15.2 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $41.38 $8.99 Million - $14.8 Million
357,403 New
357,403 $12.7 Million
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $9.13 Million - $16.7 Million
-849,899 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.0 - $20.3 $5.6 Million - $8.12 Million
399,899 Added 88.87%
849,899 $16.3 Million
Q2 2018

Aug 14, 2018

BUY
$6.37 - $14.02 $2.87 Million - $6.31 Million
450,000 New
450,000 $6.12 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.